ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

100 NSABP Sites May Enroll Patients; Only One Trial Open

July 15, 1994